Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Results of breast cancer risk assessment and hereditary cancer genetic testing in community obstetrics and gynaecology practice following a prospective quality Improvement initiative.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2026

Same author

Optimizing Hereditary Cancer Risk Assessment and Genetic Testing Workflow in Interprofessional Women's Health Practice: A Multicenter Survey of Advanced Practice Providers.

Journal of midwifery & women's health·2026

Same author

Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression.

Cancer cell·2026

Same author

Cancer Genetic Risk Assessment (CGRA) Certification: Experience from the First Five Years.

European journal of breast health·2026

Same author

Cancer Risk Assessment and Hereditary Cancer Genetic Testing in a Community OBGYN Setting.

European journal of breast health·2026

Same author

Cancer Risks Associated With Germline <i>PALB2</i> Pathogenic Variants: An International Study of 524 Families.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2019

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Cancer Genetic Risk Assessment (CGRA) Certification: Outcomes from the First Six Years.

Edith Smith^1,2, Kimberly Samuels-Bolin¹, Kristie Bobolis^1,3

¹National Consortium of Breast Centers, Indiana, USA.

European Journal of Breast Health

|June 19, 2026

Summary

This summary is machine-generated.

The Cancer Genetic Risk Assessment (CGRA) certification program has seen significant uptake, with an 88.1% pass rate among 235 examinees. This credential is highly valued by nursing professionals and advanced practice providers in oncology.

Keywords:

CGRA test outcomes

Related Experiment Videos

Last Updated: Jun 20, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Area of Science:

Oncology
Genetics
Healthcare Professional Development

Background:

Integrating cancer genetics and risk assessment is crucial for patient care.
A need exists for clinicians to demonstrate competency in cancer genetics and risk assessment.
The National Consortium of Breast Centers (NCBC) offers a Cancer Genetic Risk Assessment (CGRA) certification.

Purpose of the Study:

To describe the demographics and outcomes of the NCBC's CGRA certification program.
To analyze data from the first six years of examination availability (May 2020 - December 2025).

Main Methods:

Retrospective cohort analysis of CGRA examination takers from May 2020 to December 2025.
Data collected included total examinees, pass/fail rates, professional backgrounds, and practice settings.
Descriptive statistics were employed for data analysis.

Main Results:

A total of 235 individuals took the CGRA examination, with an 88.1% pass rate (207/235).
The majority of certificants were Advanced Practice Registered Nurses (APRNs) (52.7%) and Registered Nurses (RNs) (17.9%).
Oncology (63.8%) and Surgery (12.6%) were the predominant practice settings among certificants.

Conclusions:

The CGRA certification is a recognized and sought-after credential by a diverse range of healthcare professionals.
Nursing professionals, particularly APRNs, represent a significant portion of CGRA certificants.
The certification supports the provision of competent cancer genetic and risk assessment care across various practice settings.